Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.01 USD | +2.02% |
|
0.00% | -40.94% |
06-27 | ImmunoPrecise Antibodies Ltd. Appoints Kristin Taylor as Permanent Chief Financial Officer | CI |
06-25 | ImmunoPrecise Antibodies Unit, PGxAI to Develop AI Model to Predict Treatment Responses | MT |
Sales 2024 * | 24.59M 17.96M | Sales 2025 * | 29.82M 21.78M | Capitalization | 36.38M 26.57M |
---|---|---|---|---|---|
Net income 2024 * | -12M -8.77M | Net income 2025 * | -9M -6.57M | EV / Sales 2024 * | 1.48 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.22 x |
P/E ratio 2024 * |
-2.88
x | P/E ratio 2025 * |
-3.9
x | Employees | 102 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 86.41% |
Latest transcript on ImmunoPrecise Antibodies Ltd.
1 day | +2.02% | ||
Current month | -8.96% | ||
1 month | -9.74% | ||
3 months | -33.55% | ||
6 months | -40.59% | ||
Current year | -40.94% |
![Extreme 0.99](/images/extremecours_fleche.png)
![Extreme 0.95](/images/extremecours_fleche.png)
![Extreme 0.95](/images/extremecours_fleche.png)
![Extreme 0.94](/images/extremecours_fleche.png)
![Extreme 0.94](/images/extremecours_fleche.png)
![Extreme 0.94](/images/extremecours_fleche.png)
![Extreme 0.94](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Jennifer Bath
CEO | Chief Executive Officer | - | 18-02-20 |
Kristin Taylor
DFI | Director of Finance/CFO | - | 23-09-28 |
Ilse Roodink
CTO | Chief Tech/Sci/R&D Officer | - | 21-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mitchell Levine
CHM | Chairman | - | - |
Chris Buyse
BRD | Director/Board Member | 59 | 23-09-04 |
Jennifer Bath
CEO | Chief Executive Officer | - | 18-02-20 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-28 | 1.01 | +2.02% | 13,936 |
24-06-27 | 0.99 | -1.49% | 37,761 |
24-06-26 | 1.005 | +0.50% | 33,019 |
24-06-25 | 1 | +0.95% | 81,598 |
24-06-24 | 0.9906 | -1.92% | 30,493 |
Delayed Quote Nasdaq, June 28, 2024 at 03:57 pm
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-40.94% | 26.05M | |
+2.99% | 94.76B | |
-4.34% | 37.58B | |
-10.41% | 33.3B | |
+75.79% | 27.92B | |
-14.61% | 15.85B | |
-3.46% | 13.79B | |
-12.31% | 11.51B | |
+184.77% | 10.9B | |
-54.13% | 9.27B |
- Stock Market
- Equities
- IPA Stock